Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer

Published:2020-03-24 Issue:10 Volume:9 Page:3574-3583
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Elakad Omar¹^ORCID,Lois Anna‐Maria¹,Schmitz Katja¹,Yao Sha¹,Hugo Sara¹,Lukat Laura¹,Hinterthaner Marc²,Danner Bernhard C.²,Hammerstein‐Equord Alexander²,Reuter‐Jessen Kirsten¹,Schildhaus Hans‐Ulrich¹,Ströbel Philipp¹,Bohnenberger Hanibal¹^ORCID

Affiliation:

1. Institute of Pathology University Medical Center Göttingen Germany

2. Department of Thoracic and Cardiovascular Surgery University Medical Center Göttingen Germany

Funder

Deutsche Krebshilfe Foundation

Else-Kroener-Fresenius Foundation

University Medical Center Goettingen

Chinese Scholarship Council

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2994

Reference48 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. FGFR1 Amplification in Squamous Cell Carcinoma of The Lung

3. The biology and management of non-small cell lung cancer

4. Non-small cell lung cancer: current treatment and future advances

5. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncogene alterations in non-small cell lung cancer with FGFR1 amplification—novel approach to stratify patients who benefit from FGFR inhibitors;Translational Lung Cancer Research;2024-03

2. A Composite Biomarker Signature of Type 1 Diabetes Risk Identified via Augmentation of Parallel Multi-Omics Data from a Small Cohort;2024-02-12

3. Accurate treatment of small cell lung cancer: Current progress, new challenges and expectations;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-09

4. Expression and clinical significance of FGFR1 and FGFR2 in laryngeal squamous cell carcinoma;Translational Cancer Research;2022-09

5. Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer;npj Precision Oncology;2022-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3